Skip to Main Content

Advertisement

Skip Nav Destination

Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017

Blood (2018) 132 (Supplement 1): 2292.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement